# ENSAGE, INC. — Form D

ENSAGE, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-03. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-08-03
- Form: D
- Accession: 0001941069-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 1
- Date of first sale: 2022-07-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-454668

## Issuer

- Name: ENSAGE, INC.
- CIK: 0001941069
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 220 5TH AVENUE, 17TH FLOOR, NEW YORK, NY, 10001
- Phone: 347-218-0393

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Jeff DeFlavio | Director | New York, NY |
| Doug Elwood | Director | New York, NY |
| Kevin Ryan | Director | Rumson, NJ |
| Doug Elwood | Executive Officer | New York, NY |

## More

- [CIK 1941069 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1941069&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001941069-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.